This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Akoum, A. Articles by Maheux, R. Search for Related Content PubMed PubMed Citation Articles by Akoum, A. Articles by Maheux, R.

Estradiol and Interleukin-1ß Exert a Synergistic Stimulatory Effect on the Expression of the Chemokine Regulated upon Activation, Normal T Cell Expressed, and Secreted in Endometriotic Cells

Unité d’Endocrinologie de la Reproduction, Centre de Recherche, Hôpital Saint-François d’Assise, Centre Hospitalier Universitaire de Québec, Faculté de Médecine, Université Laval, Québec, Canada G1L 3L5

Address all correspondence and requests for reprints to: Ali Akoum, Ph.D., Laboratoire d’Endocrinologie de la Reproduction, Centre de Recherche, Hôpital Saint-François d’Assise, 10 rue de l’Espinay, Local D0–711, Québec, Canada G1L 3L5. E-mail: ali.akoum{at}crsfa.ulaval.ca.

Abstract

Endometriosis, commonly associated with intraperitoneal inflammation, is estrogen dependent. Possible links between the immunoinflammatory and endocrine changes observed in endometriotic women have been poorly understood. In this study, we report that estradiol (E₂) and IL-1ß exert a synergistic stimulatory action on RANTES (regulated upon activation, normal T cell expressed, and secreted) expression by endometriotic cells. Treatment of endometriotic cells with IL-1ß had a dose-dependent effect on RANTES protein secretion and mRNA steady state levels, whereas cell treatment with E₂ or progesterone had no detectable effect. Interestingly, treatment of endometriotic cells with E₂ before stimulation with IL-1ß resulted in a further increase in RANTES protein secretion and mRNA steady state levels, compared with IL-1ß alone, whereas treatment with progesterone did not significantly affect cell responsiveness to IL-1ß. Assessment of RANTES mRNA half-life revealed that cell pretreatment with E₂ enhanced RANTES mRNA stability and increased gene transcription as shown by run-on analysis. Immunohistochemical analysis of RANTES in endometriotic tissue showed immunostaining to be predominant in the stroma with no noticeable differences in tissues from the proliferative and secretory phase of the menstrual cycle. This appears to be consistent with the cell culture data and indicates that RANTES expression in endometriotic tissue is not subject to cyclic variation. These findings reveal a new regulatory mechanism by which IL-1ß produced by activated macrophages can in synergy with ovarian and locally produced E₂ lead to enhanced macrophage and T-lymphocyte recruitment, thereby exacerbating the local immunoinflammatory process. Furthermore, the findings provide a further evidence for a close relationship between the endocrine and immunological changes observed in endometriosis.

This article has been cited by other articles:

				Y. Hirota, S. Tranguch, T. Daikoku, A. Hasegawa, Y. Osuga, Y. Taketani, and S. K. Dey Deficiency of Immunophilin FKBP52 Promotes Endometriosis Am. J. Pathol., December 1, 2008; 173(6): 1747 - 1757. [Abstract] [Full Text] [PDF]

				S Guay and A Akoum Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology Reproduction, September 1, 2007; 134(3): 525 - 534. [Abstract] [Full Text] [PDF]

				A. Akoum, C. Lawson, C. Herrmann-Lavoie, and R. Maheux Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis Hum. Reprod., May 1, 2007; 22(5): 1464 - 1473. [Abstract] [Full Text] [PDF]

				C Lawson, M Al-Akoum, R Maheux, and A Akoum Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions Reproduction, January 1, 2007; 133(1): 265 - 274. [Abstract] [Full Text] [PDF]

				W.-G. Cao, M. Morin, C. Metz, R. Maheux, and A. Akoum Stimulation of Macrophage Migration Inhibitory Factor Expression in Endometrial Stromal Cells by Interleukin 1, beta Involving the Nuclear Transcription Factor NF{kappa}B Biol Reprod, September 1, 2005; 73(3): 565 - 570. [Abstract] [Full Text] [PDF]

				Y. Hirota, Y. Osuga, T. Hirata, O. Yoshino, K. Koga, M. Harada, C. Morimoto, E. Nose, T. Yano, O. Tsutsumi, et al. Possible Involvement of Thrombin/Protease-Activated Receptor 1 System in the Pathogenesis of Endometriosis J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3673 - 3679. [Abstract] [Full Text] [PDF]

				A. Akoum, C. N. Metz, and M. Morin Marked Increase in Macrophage Migration Inhibitory Factor Synthesis and Secretion in Human Endometrial Cells in Response to Human Chorionic Gonadotropin Hormone J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2904 - 2910. [Abstract] [Full Text] [PDF]

				C. Bellehumeur, T. Collette, R. Maheux, J. Mailloux, M. Villeneuve, and A. Akoum Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis Hum. Reprod., May 1, 2005; 20(5): 1177 - 1184. [Abstract] [Full Text] [PDF]

				R. Grummer, S.W. Hewitt, O. Traub, K.S. Korach, and E. Winterhager Different Regulatory Pathways of Endometrial Connexin Expression: Preimplantation Hormonal-Mediated Pathway Versus Embryo Implantation-Initiated Pathway Biol Reprod, July 1, 2004; 71(1): 273 - 281. [Abstract] [Full Text] [PDF]

				D. I. Lebovic, V. A. Chao, and R. N. Taylor Peritoneal Macrophages Induce RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) Chemokine Gene Transcription in Endometrial Stromal Cells J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1397 - 1401. [Abstract] [Full Text] [PDF]